Posts

Weed Not Just for Colon Cancer:

Image
Dandelion Root Extract, Prostate Cancer, and the Universality of Its Anti-Cancer Mechanisms IPCSG Newsletter Informed Prostate Cancer Support Group Spring 2026 Edition Research & Emerging Therapies   ← This article is a follow-on to our earlier piece, "The Dandelion That Fights Back," which covered dandelion root extract and colon cancer. This article expands the discussion to address whether the anti-cancer mechanisms are unique to colon cancer, and what the evidence says specifically about prostate cancer.  Our earlier article raised a question that IPCSG members immediately asked: are dandelion root's anti-cancer effects specific to colon cancer, or do they extend to prostate cancer and other tumors? The science provides a clear and encouraging answer — but with important nuances that matter to prostate cancer patients specifically. Prepared for: IPCSG Members & Cancer Community Date: March 20...

When Standard Options Are Exhausted:

Image
Could Dandelion Root Extract Have a Role in Prostate Cancer Failing ADT and Enzalutamide? IPCSG Newsletter Informed Prostate Cancer Support Group Spring 2026 Edition Editorial Analysis Editorial Analysis Third in a series on dandelion root extract and cancer — focusing on the specific clinical question of mCRPC failing standard hormonal therapy Clinical Relevance — mCRPC & Treatment-Refractory Disease This editorial directly addresses the clinical question raised by our members: given the preclinical evidence, is dandelion root extract a scientifically plausible option — as an adjunct or alternative — for men with prostate cancer that has progressed through ADT and newer agents like enzalutamide, short of radiotheranostics or chemotherapy? Prepared for: IPCSG Members — mCRPC Focus Date: March 2026 Type: Evidence-Based Editorial Analysis BLUF — Bottom Line Up Front The pr...

The Dandelion That Fights Back:

Image
What Science Now Says About Dandelion Root Extract and Colon Cancer A weed dismissed as a lawn nuisance has generated serious scientific interest — laboratory and animal studies show its root extract can kill colon cancer cells selectively and stall tumor growth dramatically. Here's an honest, up-to-date look at the evidence. Prepared for: IPCSG Members & Cancer Community Date: March 2026 Topic Category: Natural Health Products & Oncology BLUF — Bottom Line Up Front Multiple peer-reviewed laboratory and animal studies, with two major research clusters published in 2016 and 2024 and comprehensive reviews appearing through 2025, confirm that aqueous and ethanolic extracts of dandelion root ( Taraxacum officinale ) display significant anti-cancer activity against human colorectal cancer cells — killing more than 95% of cancer cells in culture within 48 hours while leaving normal healthy colon cells unharmed. In living animal m...

Momentum at the Frontier: Prostate Cancer Advances of March 2026

Image
Informed Prostate Cancer Support Group (IPCSG)  ·  Member Newsletter March 2026 Volume 2026, Issue 3 San Diego, California Research & Clinical Trials Edition March 2026 has delivered one of the most clinically consequential months in prostate cancer research in recent memory. From landmark overall survival results presented at the ASCO Genitourinary Cancers Symposium to first-in-human alpha emitter data, a $12 million research investment, and new FDA clearances for local therapy, the field has advanced simultaneously on multiple fronts — radiopharmaceuticals, precision genomics, epigenetic therapy, and focal ablation. This edition summarizes every major development our community needs to know about, with full citations and trial identifiers to aid your conversations with your oncologist.  At a Glance Summary of Key March 2026 Developments ...